2Urra X, Chamorro A. Stroke-induced immunodepression is a marker of severe brain damage, Stroke,2010,41:e110-e111.
3Schulte Herbrtiggen O, Quarcoo D. Differential affection of in- testinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation, 2009,16 :2 l3-218.
4Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians [J]. N Engl J Med, 2011,364:719-729.
5DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality : comparison of fasting and 2-hour diagnostic criteria [ J ]. Arch Intern Med, 2001,161:397- 405.
6Nakagami T, DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin[J]. Diabetologia, 2004,47:385-394.
7Barr EL, Zimmet PZ, Welbom TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) [ J ]. Circulation, 2007,116 : 151-157.
8Hirakawa Y, Ninomiya T, Mukai N, et al. Association between glucose tolerance level and cancer death in a general Japanese population : the Hisayama Study[ J]. Am J Epidemiol, 2012,176 : 856-864.
9Wen CP, Cheng TY, Tsai SP, et al. Increased mortality risks of pre-diabetes ( impaired fasting glucose) in Taiwan [ J ]. Diabetes Care, 2005, 28:2756-2761.
10The DECODE Study Group, the European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular disease? [ J]. Diabetes Care, 2003, 26:688-696.
